Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine (NEJM) of positive results from the ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

An automated insulin delivery (AID) system boosted glycemic control in insulin-treated adults with type 2 diabetes using ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...

Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor.

AID system powered by Tidepool expected to launch Q2 2025 in the U.S. with Abbott’s FreeStyle Libre® 3 Plus sensorMANCHESTER, N.H., March 18, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company ...

Ang, a Las Vegas-based 23-year-old parent program supervisor and social work grad student, began to experience dry skin, but ...

Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just ...